

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001895"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001895" />

    <meta name="citation_title" content="The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis"/>
    <meta itemprop="name" content="The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis"/>

      <meta name="citation_author" content="Idris Guessous"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland"/>
      <meta name="citation_author" content="Daniel Periard"/>
            <meta name="citation_author_institution" content="Service of Angiology, Lausanne University Hospital, Lausanne, Switzerland"/>
      <meta name="citation_author" content="Diane Lorenzetti"/>
            <meta name="citation_author_institution" content="Centre for Health and Policy Studies, Faculty of Medicine, University of Calgary, Calgary, Canada"/>
            <meta name="citation_author_institution" content="Institute of Health Economics, Edmonton, Alberta, Canada"/>
      <meta name="citation_author" content="Jacques Cornuz"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland"/>
            <meta name="citation_author_institution" content="Department of Community Medicine and Public Health, Lausanne University Hospital, Lausanne, Switzerland"/>
      <meta name="citation_author" content="William A. Ghali"/>
            <meta name="citation_author_institution" content="Centre for Health and Policy Studies, Faculty of Medicine, University of Calgary, Calgary, Canada"/>
            <meta name="citation_author_institution" content="Department of Medicine, University of Calgary, Calgary, Canada"/>
            <meta name="citation_author_institution" content="Department of Community Health Sciences, University of Calgary, Calgary, Canada"/>

    <meta name="citation_date" content="2008/3/26"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001895.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1895"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Screenning for abdominal aortic aneurysm: a best-evidence systematic review for the U.S Preventive Sevices task Force.; citation_author=C Fleming; citation_author=EP Whitelock; citation_author=TL Beil; citation_author=FA Lederle; citation_journal_title=Ann Intern Med; citation_volume=142; citation_number=1; citation_pages=203-11; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms.; citation_author=FA Lederle; citation_author=SE Wilson; citation_author=GR Johnson; citation_author=DB Reinke; citation_author=FN Littooy; citation_journal_title=N Engl J Med; citation_volume=346; citation_number=2; citation_pages=1437-44; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysm.; citation_journal_title=Lancet; citation_volume=352; citation_number=3; citation_pages=1649-1655; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Abdominal aortic aneurysm screening: 2006 recommendations.; citation_author=I Guessous; citation_author=J Cornuz; citation_journal_title=Expert Rev Pharmacoeconomics Outcomes Res; citation_volume=6; citation_number=4; citation_pages=555-561; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Screening, surgical repair, and the management of abdominal aortic aneurisms.; citation_author=RA Scott; citation_author=SG Thompson; citation_journal_title=J Med Screen; citation_volume=12; citation_number=5; citation_pages=57-58; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Expansion rates of abdominal aortic aneurysm: current limitations in evaluation.; citation_author=KA Wilson; citation_author=KR Woodburn; citation_author=CV Ruckley; citation_author=FG Fowkes; citation_journal_title=Eur J Vasc Endovasc Surg; citation_volume=13; citation_number=6; citation_pages=521-526; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung and Blood Institute.; citation_author=M Wassef; citation_author=BT Baxter; citation_author=RL Chisholm; citation_author=RL Dalman; citation_author=MF Fillinger; citation_journal_title=J Vasc Surg; citation_volume=34; citation_number=7; citation_pages=730-738; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Indomethacin prevents elastase-induced abdominal aortic aneurysm in the rat.; citation_author=DR Holmes; citation_author=D Petrinec; citation_author=W Wester; citation_author=RW Thompson; citation_author=JM Reilly; citation_journal_title=J Surg Res; citation_volume=63; citation_number=8; citation_pages=305-309; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Doxycycline inhibition of aneurismal degenration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.; citation_author=D Petrinec; citation_author=S Liao; citation_author=DR Holmes; citation_author=JM Reilly; citation_author=WC Parks; citation_journal_title=J Vasc Surg; citation_volume=23; citation_number=9; citation_pages=336-346; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Suppression of experimental aneurismal degeneration with chemically modified tetracycline derivates.; citation_author=D Petrinec; citation_author=DR Holmes; citation_author=S Liao; citation_author=LM Golub; citation_author=RW Thompson; citation_journal_title=Ann N Y Acad Sci; citation_volume=800; citation_number=10; citation_pages=263-265; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Suppression of experimental abdominal aortic aneurysm in the rat by treatment with angiotensin-converting enzyme inhibitors.; citation_author=S Liao; citation_author=M Miralles; citation_author=BJ Kelley; citation_author=JA Curci; citation_author=M Borhani; citation_journal_title=J Vasc Surg; citation_volume=33; citation_number=11; citation_pages=1057-1064; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.; citation_author=RW Thompson; citation_author=BT Baxter; citation_journal_title=Ann N Y Acad Sci; citation_volume=878; citation_number=12; citation_pages=159-178; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Identifying randomized trials.; citation_author=C Lefebvre; citation_author=M Clarke; citation_number=13; citation_pages=69-86; citation_date=2001; citation_publisher=BMJ Publishing Group; " />
      <meta name="citation_reference" content="citation_title=Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis.; citation_author=JL Deeks; citation_author=DG Altman; citation_author=MJ Bradburn; citation_number=14; citation_pages=285-312; citation_date=2001; citation_publisher=BMJ Publishing Group; " />
      <meta name="citation_reference" content="citation_title=Assessing the quality of reports of randomized clinical trials: is blinding necessary?; citation_author=AR Jadad; citation_author=RA Moore; citation_author=D Carroll; citation_author=C Jenkinson; citation_author=DJ Reynolds; citation_journal_title=Control Clin Trials; citation_volume=17; citation_number=15; citation_pages=1-12; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Explaining heterogeneity in meta-analysisis. A comparison of methods.; citation_author=S Thomson; citation_author=SJ Sharp; citation_journal_title=Stat Med; citation_volume=18; citation_number=16; citation_pages=2693-2708; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Meta-analysis in Stata™; citation_author=JA Sterne; citation_author=MJ Gradgurn; citation_author=M Egger; citation_number=17; citation_pages=347-369; citation_date=2001; citation_publisher=BMJ Publishing Group; " />
      <meta name="citation_reference" content="citation_title=An approach for assessing publication bias prior to performing a meta-analyisis.; citation_author=K Dear; citation_author=CB Begg; citation_journal_title=Stat Sci; citation_volume=7; citation_number=18; citation_pages=237-245; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Bias in meta-analysis detected by a simple, graphical test.; citation_author=M Egger; citation_author=G Davey Smith; citation_author=M Schneider; citation_author=C Minder; citation_journal_title=BMJ; citation_volume=315; citation_number=19; citation_pages=629-634; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Expansion rates of small abdominal aortic aneurysms.; citation_author=R Englund; citation_author=P Hudson; citation_author=K Hanel; citation_author=A Stanton; citation_journal_title=Aust N Z J Surg; citation_volume=68; citation_number=20; citation_pages=21-4; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.; citation_author=JS Lindholt; citation_author=EW Henneberg; citation_author=S Juul; citation_author=H Fasting; citation_journal_title=Int Angiol; citation_volume=18; citation_number=21; citation_pages=52-7; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Propranolol for small abdominal aortic aneurysms: Results of a randomized trial.; citation_journal_title=J Vasc Surg; citation_volume=35; citation_number=22; citation_pages=72-79; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Are antihypertensive drugs associated with abdominal aortic aneurysms?; citation_author=AB Wilmink; citation_author=KA Vardulaki; citation_author=CS Hubbard; citation_author=NE Day; citation_author=HA Ashton; citation_journal_title=J Vasc Surg; citation_volume=36; citation_number=23; citation_pages=751-7; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms.; citation_author=JS Lindholt; citation_author=NH Heegaard; citation_author=S Vammen; citation_author=H Fasting; citation_author=EW Henneberg; citation_journal_title=Eur J Vasc Endovasc Surg; citation_volume=21; citation_number=24; citation_pages=51-6; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.; citation_author=GR Gadowski; citation_author=DB Pilcher; citation_author=MA Ricci; citation_journal_title=J Vasc Surg; citation_volume=19; citation_number=25; citation_pages=727-31; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms.; citation_author=SD Leach; citation_author=AL Toole; citation_author=H Stern; citation_author=RW DeNatale; citation_author=MD Tilson; citation_journal_title=Arch Surg; citation_volume=123; citation_number=26; citation_pages=606-9; citation_date=1988; " />
      <meta name="citation_reference" content="citation_title=Ten-year outcome of patients with very small abdominal aortic aneurysm.; citation_author=F Biancari; citation_author=M Mosorin; citation_author=V Anttila; citation_author=J Satta; citation_author=J Juvonen; citation_journal_title=Am J Surg; citation_volume=183; citation_number=27; citation_pages=53-5; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.; citation_author=M Mosorin; citation_author=J Juvonen; citation_author=F Biancari; citation_author=J Satta; citation_author=HM Surcel; citation_journal_title=J Vasc Surg; citation_volume=34; citation_number=28; citation_pages=606-10; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion.; citation_author=S Vammen; citation_author=JS Lindholt; citation_author=L Ostergaard; citation_author=H Fasting; citation_author=EW Henneberg; citation_journal_title=Br J Surg; citation_volume=88; citation_number=29; citation_pages=1066-72; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.; citation_author=O Schouten; citation_author=JH van Laanen; citation_author=E Boersma; citation_author=R Vidakovic; citation_author=HH Feringa; citation_journal_title=Eur J Vasc Endovasc Surg; citation_volume=32; citation_number=30; citation_pages=21-6; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.; citation_author=R Sukhija; citation_author=WS Aronow; citation_author=R Sandhu; citation_author=P Kakar; citation_author=S Babu; citation_journal_title=Am J Cardiol; citation_volume=97; citation_number=31; citation_pages=279-80; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms.; citation_author=LJ Walton; citation_author=IJ Franklin; citation_author=T Bayston; citation_author=LC Brown; citation_author=RM Greenhalgh; citation_journal_title=Circulation; citation_volume=100; citation_number=32; citation_pages=48-54; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomised study; citation_author=AB Wilmink; citation_author=CS Hubbard; citation_author=NE Day; citation_author=CR Quick; citation_journal_title=Br J Surg (Abstract); citation_volume=87; citation_number=33; citation_pages=499; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance.; citation_author=AR Brady; citation_author=SG Thompson; citation_author=FG Fowkes; citation_author=RM Greenhalgh; citation_author=JT Powell; citation_journal_title=Circulation; citation_volume=110; citation_number=34; citation_pages=16-21; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms.; citation_author=DR Holmes; citation_author=W Wester; citation_author=RW Thompson; citation_author=JM Reilly; citation_journal_title=J Vasc Surg; citation_volume=25; citation_number=35; citation_pages=810-815; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Clinical epidemiology: the essentials. 3rd ed.; citation_author=RH Fletcher; citation_author=SW Fletcher; citation_author=EH Wagner; citation_number=36; citation_date=1996; citation_publisher=Lippincott Williams & Wilkins; " />
      <meta name="citation_reference" content="citation_title=Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute.; citation_author=M Wassef; citation_author=BT Baxter; citation_author=RL Chisholm; citation_author=RL Dalman; citation_author=MF Fillinger; citation_journal_title=J Vasc Surg; citation_volume=34; citation_number=37; citation_pages=730-8; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Pharmacological targets in the treatment of abdominal aortic aneurysms.; citation_author=MP Bergoeing; citation_author=RW Thompson; citation_author=JA Curci; citation_journal_title=Expert Opin Ther Targets; citation_volume=10; citation_number=38; citation_pages=547-59; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Pathogenesis of abdominal aortic aneurysm: an update and look toward the future.; citation_author=JJ Grange; citation_author=V Davis; citation_author=BT Baxter; citation_journal_title=Cardiovasc Surg; citation_volume=5; citation_number=39; citation_pages=256-65; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm.; citation_author=PK Shah; citation_journal_title=Circulation; citation_volume=96; citation_number=40; citation_pages=2115-7; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms.; citation_author=J Juvonen; citation_author=T Juvonen; citation_author=A Laurila; citation_author=H Alakarppa; citation_author=K Lounatmaa; citation_journal_title=J Vasc Surg; citation_volume=25; citation_number=41; citation_pages=499-505; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms.; citation_author=S Halme; citation_author=T Juvonen; citation_author=A Laurila; citation_author=J Juvonen; citation_author=M Mosorin; citation_journal_title=Eur J Clin Invest; citation_volume=29; citation_number=42; citation_pages=546-52; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms.; citation_author=WD McMillan; citation_author=WH Pearce; citation_journal_title=J Vasc Surg; citation_volume=29; citation_number=43; citation_pages=122-7; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.; citation_author=S Bellosta; citation_author=D Via; citation_author=M Canavesi; citation_author=P Pfister; citation_author=R Fumagalli; citation_journal_title=Arterioscler Thromb Vasc Biol; citation_volume=18; citation_number=44; citation_pages=1671-8; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.; citation_author=H Nagashima; citation_author=Y Aoka; citation_author=Y Sakomura; citation_author=A Sakuta; citation_author=S Aomi; citation_journal_title=J Vasc Surg; citation_volume=36; citation_number=45; citation_pages=158-63; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.; citation_author=Z Luan; citation_author=AJ Chase; citation_author=AC Newby; citation_journal_title=Arterioscler Thromb Vasc Bio; citation_volume=23; citation_number=46; citation_pages=769-75; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.; citation_author=WR Wilson; citation_author=J Evans; citation_author=PR Bell; citation_author=MM Thompson; citation_journal_title=Eur J Vasc Endovasc Surg; citation_volume=30; citation_number=47; citation_pages=259-62; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Why sources of heterogeneity in meta-analysis should be investigated.; citation_author=S Thompson; citation_journal_title=BMJ; citation_volume=309; citation_number=48; citation_pages=1351-1355; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.; citation_author=JL Cronenwett; citation_journal_title=Ann N Y Acad Sci; citation_volume=800; citation_number=49; citation_pages=56-67; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms.; citation_author=R Limet; citation_author=N Sakalihassan; citation_author=A Albert; citation_journal_title=J Vasc Surg; citation_volume=14; citation_number=50; citation_pages=540-8; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease.; citation_author=AT Hirsch; citation_author=ZJ Haskal; citation_author=NR Hertzer; citation_author=CW Bakal; citation_author=MA Creager; citation_journal_title=Circulation; citation_volume=113; citation_number=51; citation_pages=463-654; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Getting it right: being smarter about clinical trials.; citation_author=BS Kramer; citation_author=J Wilentz; citation_author=D Alexander; citation_author=J Burklow; citation_author=LM Friedman; citation_journal_title=PLoS Med; citation_volume=3(6); citation_number=52; citation_pages=e144; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Does the Prentice criterion validate surrogate endpoints?; citation_author=VW Berger; citation_journal_title=Stat Med; citation_volume=23; citation_number=53; citation_pages=1571-8; citation_date=2004; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis"/>
    <meta name="twitter:description" content="BackgroundPharmacotherapy may represent a potential means to limit the expansion rate of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different pharmacological agents to slow down human AAA-expansion rates have been performed, but they have never been systematically reviewed or summarized.Methods and FindingsTwo independent reviewers identified studies and selected randomized trials and prospective cohort studies comparing the growth rate of AAA in patients with pharmacotherapy vs. no pharmacotherapy. We extracted information on study interventions, baseline characteristics, methodological quality, and AAA growth rate differences (in mm/year). Fourteen prospective studies met eligibility criteria. Five cohort studies raised the possibility of benefit of beta-blockers [pooled growth rate difference: &minus;0.62 mm/year, (95%CI, &minus;1.00 to &minus;0.24)], but this was not confirmed in three beta-blocker RCTs [pooled RCT growth rate difference: &minus;0.05 mm/year (&minus;0.16 to 0.05)]. Statins have been evaluated in two cohort studies that yield a pooled growth rate difference of &minus;2.97 (&minus;5.83 to &minus;0.11). Doxycycline and roxithromycin have been evaluated in two RCTs that suggest possible benefit [pooled RCT growth rate difference: &minus;1.32 mm/year (&minus;2.89 to 0.25)]. Studies assessing NSAIDs, diuretics, calcium channel blockers and ACE inhibitors, meanwhile, did not find statistically significant differences.ConclusionsBeta-blockers do not appear to significantly reduce the growth rate of AAAs. Statins and other anti-inflammatory agents appear to hold promise for decreasing the expansion rate of AAA, but need further evaluation before definitive recommendations can be made."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001895.g002"/>

  <meta property="og:title" content="The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=2'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=5922'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=888&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001895">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001895" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001895&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Idris Guessous
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">* E-mail:</span> <a href="mailto:idris.guessous@chuv.ch">idris.guessous@chuv.ch</a></p>

                <p>Affiliation:
                  Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Daniel Periard, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Service of Angiology, Lausanne University Hospital, Lausanne, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Diane Lorenzetti, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliations:
                  Centre for Health and Policy Studies, Faculty of Medicine, University of Calgary, Calgary, Canada, 
                  Institute of Health Economics, Edmonton, Alberta, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jacques Cornuz, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliations:
                  Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland, 
                  Department of Community Medicine and Public Health, Lausanne University Hospital, Lausanne, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            William A. Ghali
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliations:
                  Centre for Health and Policy Studies, Faculty of Medicine, University of Calgary, Calgary, Canada, 
                  Department of Medicine, University of Calgary, Calgary, Canada, 
                  Department of Community Health Sciences, University of Calgary, Calgary, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 26, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001895</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001895-g001" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-t001" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-t002" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-g002" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-t003" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-t004" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t004" title="Table 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001895-t005" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t005" title="Table 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001895">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001895" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Pharmacotherapy may represent a potential means to limit the expansion rate of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different pharmacological agents to slow down human AAA-expansion rates have been performed, but they have never been systematically reviewed or summarized.</p>


<h3>Methods and Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Two independent reviewers identified studies and selected randomized trials and prospective cohort studies comparing the growth rate of AAA in patients with pharmacotherapy vs. no pharmacotherapy. We extracted information on study interventions, baseline characteristics, methodological quality, and AAA growth rate differences (in mm/year). Fourteen prospective studies met eligibility criteria. Five cohort studies raised the possibility of benefit of beta-blockers [pooled growth rate difference: −0.62 mm/year, (95%CI, −1.00 to −0.24)], but this was not confirmed in three beta-blocker RCTs [pooled RCT growth rate difference: −0.05 mm/year (−0.16 to 0.05)]. Statins have been evaluated in two cohort studies that yield a pooled growth rate difference of −2.97 (−5.83 to −0.11). Doxycycline and roxithromycin have been evaluated in two RCTs that suggest possible benefit [pooled RCT growth rate difference: −1.32 mm/year (−2.89 to 0.25)]. Studies assessing NSAIDs, diuretics, calcium channel blockers and ACE inhibitors, meanwhile, did not find statistically significant differences.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>Beta-blockers do not appear to significantly reduce the growth rate of AAAs. Statins and other anti-inflammatory agents appear to hold promise for decreasing the expansion rate of AAA, but need further evaluation before definitive recommendations can be made.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Guessous I, Periard D, Lorenzetti D, Cornuz J, Ghali WA (2008) The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis. PLoS ONE 3(3):
          e1895.
            doi:10.1371/journal.pone.0001895</p><p><strong>Editor: </strong>Antje Timmer, German Cochrane Center, Germany</p><p><strong>Received:</strong> January 23, 2008; <strong>Accepted:</strong> February 27, 2008; <strong>Published:</strong> March 26, 2008</p><p><strong>Copyright:</strong> © 2008 Guessous et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>The study was not externally funded. Dr. Ghali is funded by a Canada Research Chair, and by a Senior Health Scholar Award from the Alberta Heritage Foundation for Medical Research.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Current management recommendations for patients with small abdominal aortic aneurysms (AAA) propose interval measurements of aneurysm size until elective surgical repair is indicated based on rapid expansion or size criteria (≥5.5 cm) <a href="#pone.0001895-Fleming1">[1]</a>–<a href="#pone.0001895-The1">[3]</a>. However, AAA management based on such a “watchful-waiting” approach might not be sufficient <a href="#pone.0001895-Guessous1">[4]</a>. A more proactive strategy would be to identify AAAs by screening and then to intervene therapeutically to slow down AAA expansion with preventive measures <a href="#pone.0001895-Scott1">[5]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>A number of pharmacotherapies have potential to limit the expansion rate of small AAAs. According to previous studies, the mean growth rate of a small AAA is 0.3–0.5 cm/year <a href="#pone.0001895-Wilson1">[6]</a>. Based on this, experts propose that a reasonable therapeutic goal is to identify therapies that reduce the expansion rate from 0.5 to 0.25 cm/year (50% effectiveness) so that the typical time for a 3 cm AAA to exceed the 5.5 cm threshold for surgical consideration would be over 10 years.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>According to the different AAA pathogenesis theories, a combination of biomechanical wall stress, proteolytic degradation of aortic wall connective tissue, and inflammatory/immune response may be contributing to AAA expansion over time <a href="#pone.0001895-Wassef1">[7]</a>. Correspondingly, anti-inflammatory drugs (e.g., doxycycline, roxithromycine, and statins) and antihypertensive agents (e.g., ACE inhibitors, beta-blockers, diuretics, calcium antagonist) have been proposed and formally tested as pharmacological agents that may limit the expansion rate of small AAAs. Some of these agents have demonstrated an effective suppression of induced aneurysm formation in mouse models <a href="#pone.0001895-Holmes1">[8]</a>–<a href="#pone.0001895-Liao1">[11]</a>. Studies evaluating the efficacy of these agents to slow down human AAA-expansion rates have also been performed <a href="#pone.0001895-Thompson1">[12]</a>, but they have not to date been summarized nor characterized.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>Recognizing this, we performed a systematic review and meta-analysis of prospective human studies (clinical trials or cohort studies) that evaluated the efficacy or effectiveness of pharmacotherapies for reducing the expansion rate of AAA in patients with abdominal aortic diameter of 3.0 cm or greater. In conducting our review, we set out to systematically identify the full spectrum of pharmacological therapies that have been formally studied for the indication of reducing AAA expansion.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3>
<h4>Search strategy</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Studies were identified by searching Medline (1966 through October, 2006), EMBASE (1980 through October, 2006) and the Cochrane Controlled Clinical Trials Register (1996 through October 2006). Registered clinical trials were also searched on the <a href="http://www.ClinicalTrials.gov">www.ClinicalTrials.gov</a> website. We limited our research to randomized controlled trials and cohort studies with a concurrent control group. We did not limit our research to any specific pharmacotherapies, nor to any limited set of languages. References of review articles and congress abstracts were also searched, and a verification Medline and EMBASE search was again performed in July 2007 to ensure that there we did not miss any newly published studies. We derived 3 comprehensive search themes that were then combined using the Boolean operator “and”. We created the first theme for AAAs by using an exploded subject heading(s) and textword terms for abdominal aortic aneurysm. The second theme for our interventions of interest was created by using the Boolean search term “or” to search for broad pharmacotherapy terms appearing as exploded subject heading(s) and textword terms. We then created the third theme for study designs of interest. Cohort studies were searched by using the terms “risk”, “prognosis”, “cohort analysis” and “follow up study” and we then used the Boolean term “or” to combine combined this with a published search filter for identifying clinical trials <a href="#pone.0001895-Lefebvre1">[13]</a>. More information on the research strategy (i.e., subject heading(s) and textword terms) is available on request.</p>


<h4>Selection criteria</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Two authors (IG, DP) independently reviewed each potential study for eligibility on the basis of a predefined set of eligibility criteria. AAA was defined as an aneurysm occurring below the renal arteries and with a (anteroposterior or lateral) diameter of 3 cm or more. We excluded studies that did not report original data, those assessing patients with AAAs previously treated by surgery, those concerning aneurysms of other arteries, those concerning infectious (e.g. mycotic) AAA and those with Marfan syndrome. Pharmacotherapy interventions were defined as those involving the prescription of a drug. Other interventions such as behavioural interventions (e.g. smoking cessation) were not eligible. The follow-up had to be at least 6 months and the AAA size had to be assessed on at least two occasions for studies to be included. The main outcome measure was the mean growth rate difference in AAA diameter in mm/year between pharmacotherapy and control groups and expressed with standard deviations (SD) or related measures of dispersion. To express the size of the treatment effect in each trial, we used the difference in means (MD) and the standard error of the mean difference (SEMD), which is based on the standard deviation and the number of participants for the intervention group and the control group, respectively <a href="#pone.0001895-Deeks1">[14]</a>. Therefore, we included studies that either specifically reported SEMD, SD, or other measures of dispersion (i.e. 95% confidence intervals, or 25–75% interquartile ranges) from which SD could be calculated. We also included studies that did not report these estimates but that provided raw data from which SD could be calculated.</p>


<h4>Data extraction and quality assessment</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Two individuals (IG, DP) independently extracted data from all primary studies fulfilling eligibility criteria. Abstracted information included the study design (RCT or cohort study), the characteristics of the specific pharmacotherapy assessed in each study (including dosage and duration), the participants and study characteristics (including gender, mean age, ethnicity and proportion of smokers), as well as the type of device used to measure the AAA diameter, the number of measurements performed and the proportion of patients experiencing rupture and/or undergoing surgical intervention during follow-up. We also abstracted data on other study factors that can contribute to heterogeneity in the results of efficacy of pharmacotherapy to reduce the growth rate of AAA (i.e., baseline AAA diameter, gender, age, ethnicity, smoking status, positive family history of AAA, coronary heart disease). Any discrepancies in extracted data were resolved by a third individual (WG).</p>
<a id="article1.body1.sec2.sec3.p2" name="article1.body1.sec2.sec3.p2"></a><p>The same two reviewers independently assessed the methodological quality of identified studies. The quality of included clinical trials was evaluated by using the quality assessment scale developed by Jadad and colleagues <a href="#pone.0001895-Jadad1">[15]</a>. In addition to Jadad's scale, we also considered the type of allocation concealment. For cohort studies, meanwhile, we recorded the following quality indicators: the approach to participant recruitment (consecutive vs. other approaches); the length of follow-up; and the consideration of confounding factors. Finally, for both designs (RCT and cohort) we considered whether studies had been stopped early for benefit and if there was an a priori specification of sample size/power estimation.</p>


<h4>Statistical analysis</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>Studies were classified according to the type of agent used (e.g., beta-blockers) and to the study design (i.e., clinical trial vs. cohort). For pooling the results, we used the meta command in STATA. The meta command uses inverse-variance weighting to derive fixed-effects summary estimates of the treatment effect and the DerSimonian and Laird method for random estimate. To limit the sources of heterogeneity, we only estimated pooled growth rate differences for groups of studies that share the same type of agent and study design (e.g., RCTs evaluating beta-blockers). The presence of heterogeneity across trials was evaluated using a chi-square test for homogeneity <a href="#pone.0001895-Thomson1">[16]</a> and random-effects and fixed-effects were used accordingly to determine pooled estimates of the growth rate difference across studies <a href="#pone.0001895-Sterne1">[17]</a>. We also tested for potential publication bias using both a Begg's test for funnel plot asymmetry and an Egger's test <a href="#pone.0001895-Dear1">[18]</a>, <a href="#pone.0001895-Egger1">[19]</a>. These analyses testing for publication bias were never significant across each of the meta-analyses that we performed (detailed findings are thus not reported). We conducted the statistical analyses using STATA 9.2 software (StataCorp, College Station, Texas).</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>A total of 999 articles were identified by our initial search strategy (<a href="#pone-0001895-g001">figure 1</a>). After an initial screening step based on abstracts and article titles, 48 citations were judged to warrant further review (inter-observer kappa = 0.85). Among these, 35 citations were excluded for the following reasons: 6 did not report original data, 5 reported data already published, 2 concerned aneurysms other than AAAs, 7 were neither RCTs nor cohort studies, 9 were studies where the intervention of interest was not a drug, and 6 were studies where AAA expansion rate was not an outcome. We therefore identified 13 studies <a href="#pone.0001895-Englund1">[20]</a>–<a href="#pone.0001895-Walton1">[32]</a> for inclusion in our review (inter-observer kappa = 0.91 for the second step of selecting articles based on full text review). Among these selected studies, 4 studies met inclusion criteria but did not provide SD or equivalent to calculate the SEMD. We contacted the authors of these 4 studies <a href="#pone.0001895-Englund1">[20]</a>, <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Biancari1">[27]</a>, <a href="#pone.0001895-Walton1">[32]</a> and were successful in obtaining data needed to calculate SEMD for 3 of them <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Biancari1">[27]</a>, <a href="#pone.0001895-Walton1">[32]</a>.</p>
<div class="figure" id="pone-0001895-g001"><div class="img"><a name="pone-0001895-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1. </strong></p><a id="article1.body1.sec3.fig1.caption1.p1" name="article1.body1.sec3.fig1.caption1.p1"></a><p>Flow chart</p>
<span>doi:10.1371/journal.pone.0001895.g001</span></div><a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>Seventeen additional articles were then identified through a process of scanning reference lists and congress abstracts. Among these, 2 met eligibility criteria <a href="#pone.0001895-Wilmink2">[33]</a>, <a href="#pone.0001895-Brady1">[34]</a> and were thus included in our review. As a result of this literature review process (<a href="#pone-0001895-g001">figure 1</a>), we identified a final total of 14 studies for inclusion <a href="#pone.0001895-Lindholt1">[21]</a>–<a href="#pone.0001895-Brady1">[34]</a>. Among these, one study <a href="#pone.0001895-Wilmink1">[23]</a> reported the results of four different pharmacological agents (<a href="#pone-0001895-t001">table 1</a>).</p>
<div class="figure" id="pone-0001895-t001"><div class="img"><a name="pone-0001895-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Description of included studies</span></strong></p><span>doi:10.1371/journal.pone.0001895.t001</span></div>
<h4>Study characteristics</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>From 1988 to 2006, five RCTs <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Mosorin1">[28]</a>, <a href="#pone.0001895-Vammen1">[29]</a>, <a href="#pone.0001895-Wilmink2">[33]</a> and 9 prospective cohorts studies <a href="#pone.0001895-Wilmink1">[23]</a>–<a href="#pone.0001895-Biancari1">[27]</a>, <a href="#pone.0001895-Schouten1">[30]</a>–<a href="#pone.0001895-Sukhija1">[32]</a>,<a href="#pone.0001895-Brady1">[34]</a> have evaluated the efficacy of pharmacotherapies to reduce the growth rate of AAA (<a href="#pone-0001895-t001">table 1</a>). A total of 4804 participants were included in these studies (1995 in intervention groups, and 2809 in control groups). Two general categories of pharmacological agents have been explored within these studies: antihypertensive agents and anti-inflammatory agents. Antihypertensive agents evaluated include beta-blockers <a href="#pone.0001895-Lindholt1">[21]</a>–<a href="#pone.0001895-Biancari1">[27]</a>, <a href="#pone.0001895-Wilmink2">[33]</a>, diuretics <a href="#pone.0001895-Wilmink1">[23]</a>, ACE inhibitors <a href="#pone.0001895-Wilmink1">[23]</a>, Ca channel blockers <a href="#pone.0001895-Wilmink1">[23]</a> and unspecific antihypertensive agents <a href="#pone.0001895-Brady1">[34]</a>. Anti-inflammatory agents studied include antibiotics with anti-inflammatory properties (doxycycline and roxithromycin) <a href="#pone.0001895-Mosorin1">[28]</a>, <a href="#pone.0001895-Vammen1">[29]</a>, statins <a href="#pone.0001895-Schouten1">[30]</a>, <a href="#pone.0001895-Sukhija1">[31]</a> and nonsteroidal anti-inflammatory drugs (NSAIDs) <a href="#pone.0001895-Walton1">[32]</a>.</p>


<h4>Participant characteristics in included studies</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Age was generally reported in the included studies (10/14) and participants' mean age was 69.0 years. Participants were mostly men in the 10 studies that reported sex of the patients <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Gadowski1">[25]</a>, <a href="#pone.0001895-Leach1">[26]</a>, <a href="#pone.0001895-Mosorin1">[28]</a>–<a href="#pone.0001895-Wilmink2">[33]</a>. The proportion of smokers (current and past smokers), an established AAA risk factor, was only available in half of the studies and varied from 17% to 72% <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Mosorin1">[28]</a>–<a href="#pone.0001895-Walton1">[32]</a>. The prevalence of diabetes and hypertension were only available in four studies <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Mosorin1">[28]</a>, <a href="#pone.0001895-Sukhija1">[31]</a>, <a href="#pone.0001895-Walton1">[32]</a>. Although recognized as AAA risk factors, neither black race/ethnicity nor family history of AAA were reported in the included studies. Finally, among the studies reporting the proportion of participants with coronary heart disease (3/14), more than half of participants had histories of coronary heart disease <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Schouten1">[30]</a>, <a href="#pone.0001895-Sukhija1">[31]</a>.</p>


<h4>Annual growth rates</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>The mean AAA growth rates ranged across studies from −0.52 mm/year to 3.0 mm/year in the intervention groups and from 0.1 mm/year to 4.4 mm/year in the control groups. By medication category, the intervention and control AAA mean growth rates were 1.75 mm/year and 2.47 mm/year for beta blockers and controls, respectively; 1.53 mm/year and 2.87 mm/year for antibiotics and controls, respectively; and 0.74 mm/year and 3.8 mm/year for statins and controls, respectively (<a href="#pone-0001895-t002">table 2</a>).</p>
<div class="figure" id="pone-0001895-t002"><div class="img"><a name="pone-0001895-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Annual growth rate and growth rate difference</span></strong></p><span>doi:10.1371/journal.pone.0001895.t002</span></div>

<h4>Evidence on Efficacy of Beta-blockers</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>Beta blockers were evaluated in 3 RCTs <a href="#pone.0001895-Lindholt1">[21]</a>, <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Wilmink2">[33]</a> and in 5 prospective cohort studies <a href="#pone.0001895-Wilmink1">[23]</a>–<a href="#pone.0001895-Biancari1">[27]</a> and therefore are the most studied agent. One of the RCTs has only been published as an abstract <a href="#pone.0001895-Wilmink2">[33]</a>. A total of 1079 participants were studied in the 3 clinical trials, among whom 562 received propanolol, while 517 were control patients who did not receive beta blocker.</p>
<a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>The other 5 cohort studies included 658 participants, among whom 169 participants were treated with beta-blockers. Propanolol was the most frequently studied agent. Its dosage ranged from 20 mg/day to 240 mg/day. For three cohorts studies, neither the type of beta-blockers nor the dosage were specifically reported <a href="#pone.0001895-Wilmink1">[23]</a>, <a href="#pone.0001895-Lindholt2">[24]</a>, <a href="#pone.0001895-Biancari1">[27]</a>. In addition to propanolol, one cohort study also evaluated the effect of atenolol and metoprolol with mean doses of 68 mg/day and 80 mg/day, respectively <a href="#pone.0001895-Gadowski1">[25]</a>.</p>
<a id="article1.body1.sec3.sec4.p3" name="article1.body1.sec3.sec4.p3"></a><p>Each of the three RCTs evaluating the efficacy of beta-blockers did not individually show a significant difference in growth rate [growth rate difference: 0.28 mm/year, (CI, −0.65 to 1.21), −0.40 mm/year, (CI, −0.89 to 0.09) and −0.04 mm/year, (CI, −0.16 to 0.08)] (<a href="#pone-0001895-t002">table 2</a>). Pooling of these RCTs results did not reveal a significant growth rate difference [pooled growth rate difference from a fixed effects analysis: −0.05 mm/year, (CI, −0.44 to 0.54), heterogeneity p = 0.29] (<a href="#pone-0001895-g002">figure 2</a>, Panel A).</p>
<div class="figure" id="pone-0001895-g002"><div class="img"><a name="pone-0001895-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2. </strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>Panel A–D. Forrest plot of growth rate difference in mm/year between intervention and control group</p>
<span>doi:10.1371/journal.pone.0001895.g002</span></div><a id="article1.body1.sec3.sec4.p4" name="article1.body1.sec3.sec4.p4"></a><p>Among the five beta-blockers cohort studies, two <a href="#pone.0001895-Lindholt2">[24]</a>, <a href="#pone.0001895-Biancari1">[27]</a> showed a significant growth rate reduction (<a href="#pone-0001895-t002">table 2</a>) and pooled results from the 5 studies combined showed a significant reduction in growth rate [pooled growth rate difference from a fixed effects analysis: −0.62 mm/year, (CI, −1.00 to −0.24), hetereogeneity p = 0.11] (<a href="#pone-0001895-g002">figure 2</a>, Panel B).</p>


<h4>Evidence on efficacy of other antihypertensive agents</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>In addition to beta-blockers, a cohort study by Wilmink and colleagues <a href="#pone.0001895-Wilmink1">[23]</a> evaluated the efficacy of three other different antihypertensive agents including diuretics, ACE inhibitors and Ca channel blockers. Brady et al. <a href="#pone.0001895-Brady1">[34]</a>, meanwhile, published the results of a cohort study comparing the efficacy of ‘any antihypertensive agent’ without specifying the agents used. We report on this latter study in the general category of “other antihypertensive agents”.</p>
<a id="article1.body1.sec3.sec5.p2" name="article1.body1.sec3.sec5.p2"></a><p>Among other antihypertensive agents, all but diuretics had lower growth rates in the intervention groups relative to the corresponding control groups, but none of the observed differences were statistically significant (<a href="#pone-0001895-t002">table 2</a>). The growth rate differences were 0.10 mm/year for diuretics (CI −0.71 to 0.91), −0.78 mm/year for ACE inhibitors (CI −1.58 to 0.02), −0.30 mm/year for calcium channel blockers (CI −0.97 to 0.37) and −0.11 mm/year for any antihypertensive agent (CI −0.34 to 0.12) <a href="#pone.0001895-Wilmink1">[23]</a>, <a href="#pone.0001895-Brady1">[34]</a>. Pooling of these results was not performed because of the clinical heterogeneity of the agents studied.</p>


<h4>Evidence on efficacy of anti-inflammatory agents (antibiotics, statins, NSAIDs)</h4>
<a id="article1.body1.sec3.sec6.p1" name="article1.body1.sec3.sec6.p1"></a><p>Growth rate differences were generally larger in the studies evaluating anti-inflammatory agents than they were for anti-hypertensive agents (<a href="#pone-0001895-t002">table 2</a>). Growth rate difference exceeded −1.0 mm/year in favour of participants receiving doxycycline or roxithromycin and were even as large as −4.0 mm/year in one cohort study assessing statins <a href="#pone.0001895-Sukhija1">[31]</a>. However, upon pooling of results across studies, only statins studies reached a statistically significant level. Among the antibiotics studied, neither individual study results [growth rate difference: −1.50 mm/year, (CI, −3.93 to 0.93) and −1.19 mm/year, (CI, −3.25 to 0.87)] nor pooled results showed a significant decrease of growth rate [pooled growth rate difference from a fixed effects analysis: −1.32 mm/year, (CI, −2.89 to 0.25), heterogeneity p = 0.84] (<a href="#pone-0001895-g002">figure 2</a>, Panel C). In contrast, the two cohort studies assessing statins each showed a significant growth rate reduction with a corresponding pooled growth rate difference in a random effects analysis of −2.97 mm/year (95% CI, −5.83 to −0.11, heterogeneity p&lt;0.001) (<a href="#pone-0001895-g002">figure 2</a>, Panel D).</p>
<a id="article1.body1.sec3.sec6.p2" name="article1.body1.sec3.sec6.p2"></a><p>Only one study by Walton et al. <a href="#pone.0001895-Walton1">[32]</a> evaluated the efficacy of NSAIDs as a therapy for reducing the AAA growth rate on the basis of its suppression of cyclooxygenase 2 activity <a href="#pone.0001895-Holmes2">[35]</a>. Walton et al. reported a statistically significant median growth rate difference of −1.8 mm/year, favouring the NSAID group. We succeeded in obtaining the mean growth rate (and SD) instead of the median growth rate from the authors, and found results still favouring the NSAID group (−1.30 mm/year, 95% CI −2.59 to −0.01).</p>


<h4>Quality indicators for RCTs and Cohort Studies</h4>
<a id="article1.body1.sec3.sec7.p1" name="article1.body1.sec3.sec7.p1"></a><p><a href="#pone-0001895-t003">Table 3</a> presents our formal assessment of the RCT quality criteria that constitute the Jadad quality assessment score. Three of the five RCTs <a href="#pone.0001895-Propranolol1">[22]</a>, <a href="#pone.0001895-Mosorin1">[28]</a>, <a href="#pone.0001895-Vammen1">[29]</a> achieve scores of 4 or higher, and can therefore be characterized as high quality studies by that metric. Recognizing that the Jadad quality scale provides only a partial desription of RCT quality, we assessed additional RCT quality indicators and report these for each of the five RCTs idenfied in our review (<a href="#pone-0001895-t004">table 4</a>). It should be noted that RCT assessing beta-blockers by Wilmink and colleagues <a href="#pone.0001895-Wilmink2">[33]</a> is only published as an abstract; its quality was determined through review of an unpublished draft manuscript that the authors provided for our review.</p>
<div class="figure" id="pone-0001895-t003"><div class="img"><a name="pone-0001895-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Jadad's score and quality indicators for RCTs</span></strong></p><span>doi:10.1371/journal.pone.0001895.t003</span></div><div class="figure" id="pone-0001895-t004"><div class="img"><a name="pone-0001895-t004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t004.TIF"></span>)
                </a></li></ul></div><p><strong>Table 4.  <span>Other quality indicators for RCTs</span></strong></p><span>doi:10.1371/journal.pone.0001895.t004</span></div><a id="article1.body1.sec3.sec7.p2" name="article1.body1.sec3.sec7.p2"></a><p><a href="#pone-0001895-t005">Table 5</a> presents corresponding quality criteria for the 9 cohort studies that were included in our review. Of note, the most positive beta-blocker study <a href="#pone.0001895-Lindholt2">[24]</a> is one that fulfils only a few of the key quality criteria for cohort studies. Similarly, among the statin cohort studies, the strongly positive study by Sukhija et al. <a href="#pone.0001895-Sukhija1">[31]</a> also meets only a few of the measured quality criteria.</p>
<div class="figure" id="pone-0001895-t005"><div class="img"><a name="pone-0001895-t005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001895" data-uri="info:doi/10.1371/journal.pone.0001895.t005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001895.t005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001895.t005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001895.t005.TIF"></span>)
                </a></li></ul></div><p><strong>Table 5.  <span>Quality indicators for Cohort studies</span></strong></p><span>doi:10.1371/journal.pone.0001895.t005</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Our systematic review reveals that a number of pharmacotherapies have been studied as potential therapies for decreasing the growth rate of AAA. In fact, by not limiting our research to a specific agent, we identified thirteen different agents that have been studied either in cohort studies or RCTs since 1988. These agents are representative of the following four classes: beta-blockers (propanolol, atenolol, metoprolol), other hypertensive agents (diuretics, ACE inhibitors, Ca channel blockers), antibiotics with anti-inflammatory properties (doxycycline, roxithromycin) and other anti-inflammatory agents (simvastatins, atorvastatin, fluvastatin, pravastatin, NSAIDs). Although the majority (11/14) of studies using these agents report a trend toward a decrease of AAA expansion, only five of them are statistically significant <a href="#pone.0001895-Wilmink1">[23]</a>, <a href="#pone.0001895-Leach1">[26]</a>, <a href="#pone.0001895-Vammen1">[29]</a>, <a href="#pone.0001895-Schouten1">[30]</a>, <a href="#pone.0001895-Sukhija1">[31]</a>. The pooling of observational cohort study results suggests that beta-blockers and statins may significantly reduce the growth rate of AAA.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>Such a conclusion, however, is not supported by corresponding RCTs that reveal far less encouraging results for beta-blockers. The evidence on statins, meanwhile, is only from cohort studies. Observational studies are useful for assessing the relationship between exposure (e.g., pharmacotherapy) and disease (e.g., AAA), but they are subject to a number of potential biases <a href="#pone.0001895-Fletcher1">[36]</a>. The promising results for statins based on two observational studies are certainly important for hypothesis generation, but RCTs are now needed to confirm this hypothesis.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>For years, biomechanical wall stress mechanisms, atherosclerotic processes and high blood pressure have been proposed as causes of AAA formation <a href="#pone.0001895-Wassef2">[37]</a>. Accordingly, the efficacy of antihypertensive agents and particularly beta-blockers has been evaluated. Propanolol was one of the first agents considered, and although it appeared to reduce the growth rate of AAA in both animals and human, its effectiveness was limited by the fact that more than half of the patients dropped out of studies assessing this treatment because of side effects <a href="#pone.0001895-Bergoeing1">[38]</a>. Our systematic review shows that the AAA growth rate difference between patients treated with beta-blockers vs. controls ranges across studies from −2.70 to 0.28 mm/year. However, because the encouragingly positive pooled result from cohort studies were not confirmed in RCTs, we are led to conclude that the balance of published evidence suggests that beta-blockers do <em>not</em> significantly reduce the growth rate of AAAs, and that the use of beta-blockers, and propanolol in particular, can not be recommended for this indication.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>More recently, pathophysiological considerations have suggested that the progressive loss of aortic medial vascular smooth muscle cells and matrix in AAAs might be attributable to an inflammatory process due to the proteolytic depletion of medial and adventitial elastin <a href="#pone.0001895-Grange1">[39]</a>, <a href="#pone.0001895-Shah1">[40]</a>. These processes involve an elastolytic proteinase called elastolytic matrix metalloproteinase (MMP). In keeping with this inflammatory hypothesis, it has also been proposed that an infectious agent, <em>Chlamydia pneumonia,</em> might be involved as an initiating or accelerating agent in the process leading to aneurysm formation and expansion <a href="#pone.0001895-Juvonen1">[41]</a>, <a href="#pone.0001895-Halme1">[42]</a>. Accordingly, the efficacy of anti-inflammatory agents, including antibiotics, has been evaluated in a number of studies assessing the growth rate of AAAs. Antibiotics were the first anti-inflammatory agents evaluated in randomized trials. Mosorin et al. <a href="#pone.0001895-Mosorin1">[28]</a>, assessing doxycycline, found that the overall aneurysm expansion rate during 18-month follow up was higher in the placebo group (3.0 mm) than in the doxycycline group (1.5 mm), but the difference did not reach statistical significance <a href="#pone.0001895-Mosorin1">[28]</a>. They attributed their lack of statistical significance to their small sample size (n = 32). Using a macrolide (roxithromycin) in a larger RCT, Vammen et al. found a significant difference between the intervention group and the control group after one year, but not after a second year of follow-up <a href="#pone.0001895-Vammen1">[29]</a>. Because our analysis considered only the difference measured at the end of follow-up for all studies, our meta-analysis reports a non-sigificant finding for this latter study.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>Because elastolytic matrix metalloproteinase (MMP) has been implicated in AAA formation and expansion, drugs inhibiting MMP action have been proposed as an approach to reducing the growth rate of AAAs <a href="#pone.0001895-McMillan1">[43]</a>. Intriguingly, recent immunohistochemistry studies and animals studies have shown that statins possess MMP inhibiting properties <a href="#pone.0001895-Bellosta1">[44]</a>,<a href="#pone.0001895-Nagashima1"></a>–<a href="#pone.0001895-Luan1"></a>,<a href="#pone.0001895-Wilson2">[47]</a>. In keeping with this hypothesis, the two cohort studies of statins that we identified in our review <a href="#pone.0001895-Schouten1">[30]</a>, <a href="#pone.0001895-Sukhija1">[31]</a> suggest a notable growth rate difference. As mentioned earlier, however, this evidence is from non-randomized cohort studies of statins, at least one of which <a href="#pone.0001895-Sukhija1">[31]</a> had suboptimal study quality according to our assessment of cohort study quality markers (<a href="#pone-0001895-t005">table 5</a>).</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>The assessment of study quality revealed that most studies reported on the key indicators of quality. The most frequently missing quality indicators concerned observational cohort studies and consisted of incomplete or lack of reporting on losses to follow-up, no report of adverse events, no sample size specification, and the suboptimal reporting of important baseline characteristics (e.g., smoking status, hypertension). Furthermore, although we carefully searched and reported on quality indicators among the included cohort studies, it should be emphasized that the most important quality indicator is actually the study design. Therefore, the results in our analysis emerging from RCTs should be considered of higher quality than results from observational cohort studies.</p>
<a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7"></a><p>Our study has limitations. First, although we believe that we have identified all available studies through a comprehensive and sensitive search strategy and by seeking unpublished data from study authors, it is possible that we have missed some studies. Second, we found some evidence for statistical heterogeneity among statins studies (<a href="#pone-0001895-g002">figure 2</a>, panel D) and the presence of heterogeneity can compromise the interpretation <a href="#pone.0001895-Thompson2">[48]</a>. These two statin studies used different classes of statins and one of the studies did not report the dose. These are clinical differences that may have contributed to the heterogeneity of results that we observed. We therefore emphasize the need to consider the corresponding pooled growth rate difference for statins with caution. A third general limitation to our review is that we would globally characterize the body of literature that we have summarized as being non-definitive, and in need of further study before firm treatment recommendations can be made. With perhaps the exception of the RCT beta-blocker evidence suggesting lack of benefit, the studies assessing other therapies (including the promising category of anti-inflammatory agents) is predominantly observational in nature, and not optimal from the standpoint of study quality and/or sample sizes. This global limitation, inherent to the body of literature that we summarized, points to a need for more RCTs assessing pharmacotherapies (especially anti-inflammatory therapies) for AAA growth rate reduction before more definitive recommendations can be made. Finally, it is worth noting that although AAA expansion rate is associated with the risk of AAA rupture <a href="#pone.0001895-Cronenwett1">[49]</a>, <a href="#pone.0001895-Limet1">[50]</a>, and that expansion rate is currently used as an indication for intervention (e.g. AAA repair) <a href="#pone.0001895-Hirsch1">[51]</a>, it is only a surrogate marker of increased rupture rate. The use of surrogate markers as endpoints presents some study feasibility advantages <a href="#pone.0001895-Kramer1">[52]</a>, but improvement in a surrogate endpoint does not itself confer a definitive proof of patient benefit (i.e., a decrease in risk of AAA rupture) <a href="#pone.0001895-Berger1">[53]</a>. Although both statistical and mechanistic elements suggested that AAA expansion rate is a valid surrogate marker of AAA rupture, definitive inference is only likely when using the true clinical endpoint (i.e. AAA rupture).</p>
<a id="article1.body1.sec4.p8" name="article1.body1.sec4.p8"></a><p>While we wait for such trials to be performed, clinicians will rightly pose the question of whether they should now begin prescribing various pharmacotherapies to patients with AAA? To the best of our knowledge, our study is the first to systematically review and meta-analyze the literature assessing this clinical question. Although our review findings lead us to suggest that beta-blockers do not reduce AAA growth rate, the use of surrogate markers and the small number of RCTs assessing the efficacy of beta-blockers do not definitively exclude the possibility of benefit from beta-blockers. Anti-inflammatory agents, and in particular statins, meanwhile, appear promising based on observational cohort studies. In the absence of more definitive RCT evidence, we cannot recommend use of these agents for the sole indication of reducing AAA expansion rate. If, however, clinicians are in the common scenario of having a patient with a AAA and concomitant coronary artery disease and/or hyperlipidemia, we would recommend the use of statins as these will provide established benefit for the patient's vascular disease risk, and potentially also benefit to the rate of AAA expansion.</p>
<a id="article1.body1.sec4.p9" name="article1.body1.sec4.p9"></a><p>Our review indicates that beta-blockers do not significantly reduce the growth rate of AAAs. Other pharmacotherapies, and particularly anti-inflammatory agents, hold promise for reducing the expansion rate of AAAs greater than 3cm. The literature summarized, however, constitutes a non-definitive body of evidence with most of the studies identified being observational cohort studies. There is now a need for randomized controlled trials in this area, particularly for the promising anti-inflammatory agents.</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank Drs Janet Powell (Imperial College, United Kingdom), Jes Lindholt (Hospital of Viborg, Denmark), Raymond Englund (St George Hospital, Australia), Antonius Wilmink (Birmingham Heartlands Hospital, United Kingdom), and Fausto Biancari (Oulu University Hospital, Finland), who supplied at our request additional data from their studies in a written communication.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: JC IG WG DP. Analyzed the data: JC IG WG DP. Wrote the paper: IG WG. Other: Wrote the first draft of the paper: IG. Critically reviewed the draft: DL WG JC DP. Perfomed the search strategy: DL.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001895-Fleming1" id="pone.0001895-Fleming1"></a>Fleming C, Whitelock EP, Beil TL, Lederle FA (2005) Screenning for abdominal aortic aneurysm: a best-evidence systematic review for the U.S Preventive Sevices task Force. Ann Intern Med  142: 203–11.  <ul class="find" data-citedArticleID="1083276" data-doi="10.7326/0003-4819-142-3-200502010-00012"><li><a href="http://dx.doi.org/10.7326/0003-4819-142-3-200502010-00012" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Screenning+for+abdominal+aortic+aneurysm%3A+a+best-evidence+systematic+review+for+the+U.S+Preventive+Sevices+task+Force." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Screenning+for+abdominal+aortic+aneurysm%3A+a+best-evidence+systematic+review+for+the+U.S+Preventive+Sevices+task+Force.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001895-Lederle1" id="pone.0001895-Lederle1"></a>Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, et al.  (2002) Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med  346: 1437–44.  <ul class="find" data-citedArticleID="1083302" data-doi="10.1056/nejmoa012573"><li><a href="http://dx.doi.org/10.1056/nejmoa012573" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Aneurysm+Detection+and+Management+Veterans+Affairs+Cooperative+Study+Group.+Immediate+repair+compared+with+surveillance+of+small+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Aneurysm+Detection+and+Management+Veterans+Affairs+Cooperative+Study+Group.+Immediate+repair+compared+with+surveillance+of+small+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001895-The1" id="pone.0001895-The1"></a>The UK Small Aneurysm trial Participants (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysm. Lancet  352: 1649–1655.  <ul class="find" data-citedArticleID="1083338" data-doi="10.1016/s0140-6736(98)10137-x"><li><a href="http://dx.doi.org/10.1016/s0140-6736(98)10137-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mortality+results+for+randomised+controlled+trial+of+early+elective+surgery+or+ultrasonographic+surveillance+for+small+abdominal+aortic+aneurysm." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mortality+results+for+randomised+controlled+trial+of+early+elective+surgery+or+ultrasonographic+surveillance+for+small+abdominal+aortic+aneurysm.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001895-Guessous1" id="pone.0001895-Guessous1"></a>Guessous I, Cornuz J (2006) Abdominal aortic aneurysm screening: 2006 recommendations. Expert Rev Pharmacoeconomics Outcomes Res  6: 555–561.  <ul class="find" data-citedArticleID="1083284" data-doi="10.1586/14737167.6.5.555"><li><a href="http://dx.doi.org/10.1586/14737167.6.5.555" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abdominal+aortic+aneurysm+screening%3A+2006+recommendations." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abdominal+aortic+aneurysm+screening%3A+2006+recommendations.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001895-Scott1" id="pone.0001895-Scott1"></a>Scott RA, Thompson SG (2005) Screening, surgical repair, and the management of abdominal aortic aneurisms. J Med Screen  12: 57–58.  <ul class="find" data-citedArticleID="1083330"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Screening%2C+surgical+repair%2C+and+the+management+of+abdominal+aortic+aneurisms.&amp;auth=&amp;atitle=Screening%2C+surgical+repair%2C+and+the+management+of+abdominal+aortic+aneurisms." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Screening%2C+surgical+repair%2C+and+the+management+of+abdominal+aortic+aneurisms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Screening%2C+surgical+repair%2C+and+the+management+of+abdominal+aortic+aneurisms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001895-Wilson1" id="pone.0001895-Wilson1"></a>Wilson KA, Woodburn KR, Ruckley CV, Fowkes FG (1997) Expansion rates of abdominal aortic aneurysm: current limitations in evaluation. Eur J Vasc Endovasc Surg  13: 521–526.  <ul class="find" data-citedArticleID="1083358" data-doi="10.1016/s1078-5884(97)80059-7"><li><a href="http://dx.doi.org/10.1016/s1078-5884(97)80059-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expansion+rates+of+abdominal+aortic+aneurysm%3A+current+limitations+in+evaluation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expansion+rates+of+abdominal+aortic+aneurysm%3A+current+limitations+in+evaluation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001895-Wassef1" id="pone.0001895-Wassef1"></a>Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fillinger MF, et al.  (2001) Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung and Blood Institute. J Vasc Surg  34: 730–738.  <ul class="find" data-citedArticleID="1083350" data-doi="10.1067/mva.2001.116966"><li><a href="http://dx.doi.org/10.1067/mva.2001.116966" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pathogenesis+of+abdominal+aortic+aneurysms%3A+a+multidisciplinary+research+program+supported+by+the+National+Heart%2C+Lung+and+Blood+Institute." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pathogenesis+of+abdominal+aortic+aneurysms%3A+a+multidisciplinary+research+program+supported+by+the+National+Heart%2C+Lung+and+Blood+Institute.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001895-Holmes1" id="pone.0001895-Holmes1"></a>Holmes DR, Petrinec D, Wester W, Thompson RW, Reilly JM (1996) Indomethacin prevents elastase-induced abdominal aortic aneurysm in the rat. J Surg Res  63: 305–309.  <ul class="find" data-citedArticleID="1083290" data-doi="10.1006/jsre.1996.0265"><li><a href="http://dx.doi.org/10.1006/jsre.1996.0265" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Indomethacin+prevents+elastase-induced+abdominal+aortic+aneurysm+in+the+rat." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Indomethacin+prevents+elastase-induced+abdominal+aortic+aneurysm+in+the+rat.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001895-Petrinec1" id="pone.0001895-Petrinec1"></a>Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, et al.  (1996) Doxycycline inhibition of aneurismal degenration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg  23: 336–346.  <ul class="find" data-citedArticleID="1083322" data-doi="10.1016/s0741-5214(96)70279-3"><li><a href="http://dx.doi.org/10.1016/s0741-5214(96)70279-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Doxycycline+inhibition+of+aneurismal+degenration+in+an+elastase-induced+rat+model+of+abdominal+aortic+aneurysm%3A+preservation+of+aortic+elastin+associated+with+suppressed+production+of+92+kD+gelatinase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Doxycycline+inhibition+of+aneurismal+degenration+in+an+elastase-induced+rat+model+of+abdominal+aortic+aneurysm%3A+preservation+of+aortic+elastin+associated+with+suppressed+production+of+92+kD+gelatinase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001895-Petrinec2" id="pone.0001895-Petrinec2"></a>Petrinec D, Holmes DR, Liao S, Golub LM, Thompson RW (1996) Suppression of experimental aneurismal degeneration with chemically modified tetracycline derivates. Ann N Y Acad Sci  800: 263–265.  <ul class="find" data-citedArticleID="1083324" data-doi="10.1111/j.1749-6632.1996.tb33326.x"><li><a href="http://dx.doi.org/10.1111/j.1749-6632.1996.tb33326.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Suppression+of+experimental+aneurismal+degeneration+with+chemically+modified+tetracycline+derivates." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Suppression+of+experimental+aneurismal+degeneration+with+chemically+modified+tetracycline+derivates.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001895-Liao1" id="pone.0001895-Liao1"></a>Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, et al.  (2001) Suppression of experimental abdominal aortic aneurysm in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg  33: 1057–1064.  <ul class="find" data-citedArticleID="1083306" data-doi="10.1067/mva.2001.112810"><li><a href="http://dx.doi.org/10.1067/mva.2001.112810" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Suppression+of+experimental+abdominal+aortic+aneurysm+in+the+rat+by+treatment+with+angiotensin-converting+enzyme+inhibitors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Suppression+of+experimental+abdominal+aortic+aneurysm+in+the+rat+by+treatment+with+angiotensin-converting+enzyme+inhibitors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001895-Thompson1" id="pone.0001895-Thompson1"></a>Thompson RW, Baxter BT (1999) MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci  878: 159–178.  <ul class="find" data-citedArticleID="1083340" data-doi="10.1111/j.1749-6632.1999.tb07682.x"><li><a href="http://dx.doi.org/10.1111/j.1749-6632.1999.tb07682.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=MMP+inhibition+in+abdominal+aortic+aneurysms.+Rationale+for+a+prospective+randomized+clinical+trial." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22MMP+inhibition+in+abdominal+aortic+aneurysms.+Rationale+for+a+prospective+randomized+clinical+trial.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001895-Lefebvre1" id="pone.0001895-Lefebvre1"></a>Lefebvre C, Clarke M (2001)  Identifying randomized trials. In: Egger M, Davey Smith G, Altman DG, editors. Systematic Reviews in Health Care: Meta-analysis in Context. London, United Kingdom: BMJ Publishing Group. pp. 69–86.  <ul class="find-nolinks"></ul></li><li><span class="label">14.
              </span><a name="pone.0001895-Deeks1" id="pone.0001895-Deeks1"></a>Deeks JL, Altman DG, Bradburn MJ (2001)  Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. Meta-analysis in Context. London, United Kingdom: BMJ Publishing Group. pp. 285–312.  <ul class="find-nolinks"></ul></li><li><span class="label">15.
              </span><a name="pone.0001895-Jadad1" id="pone.0001895-Jadad1"></a>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al.  (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials  17: 1–12.  <ul class="find" data-citedArticleID="1083294" data-doi="10.1016/0197-2456(95)00134-4"><li><a href="http://dx.doi.org/10.1016/0197-2456(95)00134-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Assessing+the+quality+of+reports+of+randomized+clinical+trials%3A+is+blinding+necessary%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Assessing+the+quality+of+reports+of+randomized+clinical+trials%3A+is+blinding+necessary%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001895-Thomson1" id="pone.0001895-Thomson1"></a>Thomson S, Sharp SJ (1999) Explaining heterogeneity in meta-analysisis. A comparison of methods. Stat Med  18: 2693–2708.  <ul class="find" data-citedArticleID="1083344" data-doi="10.1002/(sici)1097-0258(19991030)18:20<2693::aid-sim235&gt;3.0.co;2-v"><li><a href="http://dx.doi.org/10.1002/(sici)1097-0258(19991030)18:20<2693::aid-sim235&gt;3.0.co;2-v" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Explaining+heterogeneity+in+meta-analysisis.+A+comparison+of+methods." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Explaining+heterogeneity+in+meta-analysisis.+A+comparison+of+methods.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001895-Sterne1" id="pone.0001895-Sterne1"></a>Sterne JA, Gradgurn MJ, Egger M (2001)  Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. Meta-analysis in Context. London, United Kingdom: BMJ Publishing Group. pp. 347–369.  <ul class="find-nolinks"></ul></li><li><span class="label">18.
              </span><a name="pone.0001895-Dear1" id="pone.0001895-Dear1"></a>Dear K, Begg CB (1992) An approach for assessing publication bias prior to performing a meta-analyisis. Stat Sci  7: 237–245.  <ul class="find" data-citedArticleID="1083268" data-doi="10.1214/ss/1177011363"><li><a href="http://dx.doi.org/10.1214/ss/1177011363" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=An+approach+for+assessing+publication+bias+prior+to+performing+a+meta-analyisis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22An+approach+for+assessing+publication+bias+prior+to+performing+a+meta-analyisis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001895-Egger1" id="pone.0001895-Egger1"></a>Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ  315: 629–634.  <ul class="find" data-citedArticleID="1083272" data-doi="10.1136/bmj.315.7109.629"><li><a href="http://dx.doi.org/10.1136/bmj.315.7109.629" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bias+in+meta-analysis+detected+by+a+simple%2C+graphical+test." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bias+in+meta-analysis+detected+by+a+simple%2C+graphical+test.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001895-Englund1" id="pone.0001895-Englund1"></a>Englund R, Hudson P, Hanel K, Stanton A (1998) Expansion rates of small abdominal aortic aneurysms. Aust N Z J Surg  68: 21–4.  <ul class="find" data-citedArticleID="1083274" data-doi="10.1111/j.1445-2197.1998.tb04630.x"><li><a href="http://dx.doi.org/10.1111/j.1445-2197.1998.tb04630.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expansion+rates+of+small+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expansion+rates+of+small+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001895-Lindholt1" id="pone.0001895-Lindholt1"></a>Lindholt JS, Henneberg EW, Juul S, Fasting H (1999) Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol  18: 52–7.  <ul class="find" data-citedArticleID="1083310"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Impaired+results+of+a+randomised+double+blinded+clinical+trial+of+propranolol+versus+placebo+on+the+expansion+rate+of+small+abdominal+aortic+aneurysms.&amp;auth=&amp;atitle=Impaired+results+of+a+randomised+double+blinded+clinical+trial+of+propranolol+versus+placebo+on+the+expansion+rate+of+small+abdominal+aortic+aneurysms." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Impaired+results+of+a+randomised+double+blinded+clinical+trial+of+propranolol+versus+placebo+on+the+expansion+rate+of+small+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Impaired+results+of+a+randomised+double+blinded+clinical+trial+of+propranolol+versus+placebo+on+the+expansion+rate+of+small+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001895-Propranolol1" id="pone.0001895-Propranolol1"></a>Propranolol Aneurysm Trial Investigators (2002) Propranolol for small abdominal aortic aneurysms: Results of a randomized trial. J Vasc Surg  35: 72–79.  <ul class="find" data-citedArticleID="1083326" data-doi="10.1067/mva.2002.121308"><li><a href="http://dx.doi.org/10.1067/mva.2002.121308" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Propranolol+for+small+abdominal+aortic+aneurysms%3A+Results+of+a+randomized+trial." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Propranolol+for+small+abdominal+aortic+aneurysms%3A+Results+of+a+randomized+trial.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001895-Wilmink1" id="pone.0001895-Wilmink1"></a>Wilmink AB, Vardulaki KA, Hubbard CS, Day NE, Ashton HA, et al.  (2002) Are antihypertensive drugs associated with abdominal aortic aneurysms? J Vasc Surg  36: 751–7.  <ul class="find" data-citedArticleID="1083354" data-doi="10.1067/mva.2002.126550"><li><a href="http://dx.doi.org/10.1067/mva.2002.126550" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Are+antihypertensive+drugs+associated+with+abdominal+aortic+aneurysms%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Are+antihypertensive+drugs+associated+with+abdominal+aortic+aneurysms%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001895-Lindholt2" id="pone.0001895-Lindholt2"></a>Lindholt JS, Heegaard NH, Vammen S, Fasting H, Henneberg EW, et al.  (2001) Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg  21: 51–6.  <ul class="find" data-citedArticleID="1083312" data-doi="10.1053/ejvs.2000.1262"><li><a href="http://dx.doi.org/10.1053/ejvs.2000.1262" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Smoking%2C+but+not+lipids%2C+lipoprotein%28a%29+and+antibodies+against+oxidised+LDL%2C+is+correlated+to+the+expansion+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Smoking%2C+but+not+lipids%2C+lipoprotein%28a%29+and+antibodies+against+oxidised+LDL%2C+is+correlated+to+the+expansion+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001895-Gadowski1" id="pone.0001895-Gadowski1"></a>Gadowski GR, Pilcher DB, Ricci MA (1994) Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg  19: 727–31.  <ul class="find" data-citedArticleID="1083280" data-doi="10.1016/s0741-5214(94)70048-6"><li><a href="http://dx.doi.org/10.1016/s0741-5214(94)70048-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abdominal+aortic+aneurysm+expansion+rate%3A+effect+of+size+and+beta-adrenergic+blockade." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abdominal+aortic+aneurysm+expansion+rate%3A+effect+of+size+and+beta-adrenergic+blockade.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001895-Leach1" id="pone.0001895-Leach1"></a>Leach SD, Toole AL, Stern H, DeNatale RW, Tilson MD (1988) Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch Surg  123: 606–9.  <ul class="find" data-citedArticleID="1083300" data-doi="10.1001/archsurg.1988.01400290092015"><li><a href="http://dx.doi.org/10.1001/archsurg.1988.01400290092015" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+of+beta-adrenergic+blockade+on+the+growth+rate+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+of+beta-adrenergic+blockade+on+the+growth+rate+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001895-Biancari1" id="pone.0001895-Biancari1"></a>Biancari F, Mosorin M, Anttila V, Satta J, Juvonen J, et al.  (2002) Ten-year outcome of patients with very small abdominal aortic aneurysm. Am J Surg  183: 53–5.  <ul class="find" data-citedArticleID="1083262" data-doi="10.1016/s0002-9610(01)00828-5"><li><a href="http://dx.doi.org/10.1016/s0002-9610(01)00828-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ten-year+outcome+of+patients+with+very+small+abdominal+aortic+aneurysm." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ten-year+outcome+of+patients+with+very+small+abdominal+aortic+aneurysm.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001895-Mosorin1" id="pone.0001895-Mosorin1"></a>Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, et al.  (2001) Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg  34: 606–10.  <ul class="find" data-citedArticleID="1083318" data-doi="10.1067/mva.2001.117891"><li><a href="http://dx.doi.org/10.1067/mva.2001.117891" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Use+of+doxycycline+to+decrease+the+growth+rate+of+abdominal+aortic+aneurysms%3A+a+randomized%2C+double-blind%2C+placebo-controlled+pilot+study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Use+of+doxycycline+to+decrease+the+growth+rate+of+abdominal+aortic+aneurysms%3A+a+randomized%2C+double-blind%2C+placebo-controlled+pilot+study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001895-Vammen1" id="pone.0001895-Vammen1"></a>Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW (2001) Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg  88: 1066–72.  <ul class="find" data-citedArticleID="1083346" data-doi="10.1046/j.0007-1323.2001.01845.x"><li><a href="http://dx.doi.org/10.1046/j.0007-1323.2001.01845.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Randomized+double-blind+controlled+trial+of+roxithromycin+for+prevention+of+abdominal+aortic+aneurysm+expansion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Randomized+double-blind+controlled+trial+of+roxithromycin+for+prevention+of+abdominal+aortic+aneurysm+expansion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001895-Schouten1" id="pone.0001895-Schouten1"></a>Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, et al.  (2006) Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg  32: 21–6.  <ul class="find" data-citedArticleID="1083328" data-doi="10.1016/j.ejvs.2005.12.024"><li><a href="http://dx.doi.org/10.1016/j.ejvs.2005.12.024" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Statins+are+associated+with+a+reduced+infrarenal+abdominal+aortic+aneurysm+growth." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Statins+are+associated+with+a+reduced+infrarenal+abdominal+aortic+aneurysm+growth.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001895-Sukhija1" id="pone.0001895-Sukhija1"></a>Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol  97: 279–80.  <ul class="find" data-citedArticleID="1083336" data-doi="10.1016/j.amjcard.2005.08.033"><li><a href="http://dx.doi.org/10.1016/j.amjcard.2005.08.033" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mortality+and+size+of+abdominal+aortic+aneurysm+at+long-term+follow-up+of+patients+not+treated+surgically+and+treated+with+and+without+statins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mortality+and+size+of+abdominal+aortic+aneurysm+at+long-term+follow-up+of+patients+not+treated+surgically+and+treated+with+and+without+statins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001895-Walton1" id="pone.0001895-Walton1"></a>Walton LJ, Franklin IJ, Bayston T, Brown LC, Greenhalgh RM, et al.  (1999) Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation  100: 48–54.  <ul class="find" data-citedArticleID="1083348" data-doi="10.1161/01.cir.100.1.48"><li><a href="http://dx.doi.org/10.1161/01.cir.100.1.48" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+prostaglandin+E2+synthesis+in+abdominal+aortic+aneurysms%3A+implications+for+smooth+muscle+cell+viability%2C+inflammatory+processes%2C+and+the+expansion+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+prostaglandin+E2+synthesis+in+abdominal+aortic+aneurysms%3A+implications+for+smooth+muscle+cell+viability%2C+inflammatory+processes%2C+and+the+expansion+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001895-Wilmink2" id="pone.0001895-Wilmink2"></a>Wilmink AB, Hubbard CS, Day NE, Quick CR (2000) Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomised study Br J Surg (Abstract)  87: 499.  <ul class="find" data-citedArticleID="1083356" data-doi="10.1046/j.1365-2168.2000.01420-23.x"><li><a href="http://dx.doi.org/10.1046/j.1365-2168.2000.01420-23.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+of+propanolol+on+the+expansion+of+abdominal+aortic+aneurysms%3A+a+randomised+study" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+of+propanolol+on+the+expansion+of+abdominal+aortic+aneurysms%3A+a+randomised+study%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001895-Brady1" id="pone.0001895-Brady1"></a>Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT, UK Small Aneurysm Trial Participants (2004) Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation  110: 16–21.  <ul class="find" data-citedArticleID="1083264" data-doi="10.1016/j.accreview.2004.08.085"><li><a href="http://dx.doi.org/10.1016/j.accreview.2004.08.085" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abdominal+aortic+aneurysm+expansion%3A+risk+factors+and+time+intervals+for+surveillance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abdominal+aortic+aneurysm+expansion%3A+risk+factors+and+time+intervals+for+surveillance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001895-Holmes2" id="pone.0001895-Holmes2"></a>Holmes DR, Wester W, Thompson RW, Reilly JM (1997) Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Surg  25: 810–815.  <ul class="find" data-citedArticleID="1083292" data-doi="10.1016/s0741-5214(97)70210-6"><li><a href="http://dx.doi.org/10.1016/s0741-5214(97)70210-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prostaglandin+E2+synthesis+and+cyclooxygenase+expression+in+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prostaglandin+E2+synthesis+and+cyclooxygenase+expression+in+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001895-Fletcher1" id="pone.0001895-Fletcher1"></a>Fletcher RH, Fletcher SW, Wagner EH (1996) Clinical epidemiology: the essentials. 3<sup>rd</sup> ed. Philadelphia: Lippincott Williams &amp; Wilkins.   <ul class="find-nolinks"></ul></li><li><span class="label">37.
              </span><a name="pone.0001895-Wassef2" id="pone.0001895-Wassef2"></a>Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fillinger MF, et al.  (2001) Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg  34: 730–8.  <ul class="find" data-citedArticleID="1083352" data-doi="10.1067/mva.2001.116966"><li><a href="http://dx.doi.org/10.1067/mva.2001.116966" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pathogenesis+of+abdominal+aortic+aneurysms%3A+a+multidisciplinary+research+program+supported+by+the+National+Heart%2C+Lung%2C+and+Blood+Institute." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pathogenesis+of+abdominal+aortic+aneurysms%3A+a+multidisciplinary+research+program+supported+by+the+National+Heart%2C+Lung%2C+and+Blood+Institute.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001895-Bergoeing1" id="pone.0001895-Bergoeing1"></a>Bergoeing MP, Thompson RW, Curci JA (2006) Pharmacological targets in the treatment of abdominal aortic aneurysms. Expert Opin Ther Targets  10: 547–59.  <ul class="find" data-citedArticleID="1083260" data-doi="10.1517/14728222.10.4.547"><li><a href="http://dx.doi.org/10.1517/14728222.10.4.547" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pharmacological+targets+in+the+treatment+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pharmacological+targets+in+the+treatment+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001895-Grange1" id="pone.0001895-Grange1"></a>Grange JJ, Davis V, Baxter BT (1997) Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc Surg  5: 256–65.  <ul class="find" data-citedArticleID="1083282" data-doi="10.1016/s0967-2109(97)00018-5"><li><a href="http://dx.doi.org/10.1016/s0967-2109(97)00018-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pathogenesis+of+abdominal+aortic+aneurysm%3A+an+update+and+look+toward+the+future." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pathogenesis+of+abdominal+aortic+aneurysm%3A+an+update+and+look+toward+the+future.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001895-Shah1" id="pone.0001895-Shah1"></a>Shah PK (1997) Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation  96: 2115–7.  <ul class="find" data-citedArticleID="1083332" data-doi="10.1161/01.cir.96.7.2115"><li><a href="http://dx.doi.org/10.1161/01.cir.96.7.2115" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inflammation%2C+metalloproteinases%2C+and+increased+proteolysis%3A+an+emerging+pathophysiological+paradigm+in+aortic+aneurysm." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inflammation%2C+metalloproteinases%2C+and+increased+proteolysis%3A+an+emerging+pathophysiological+paradigm+in+aortic+aneurysm.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0001895-Juvonen1" id="pone.0001895-Juvonen1"></a>Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, et al.  (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg  25: 499–505.  <ul class="find" data-citedArticleID="1083296" data-doi="10.1016/s0741-5214(97)70260-x"><li><a href="http://dx.doi.org/10.1016/s0741-5214(97)70260-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Demonstration+of+Chlamydia+pneumoniae+in+the+walls+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Demonstration+of+Chlamydia+pneumoniae+in+the+walls+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0001895-Halme1" id="pone.0001895-Halme1"></a>Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, et al.  (1999) Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest  29: 546–52.  <ul class="find" data-citedArticleID="1083286" data-doi="10.1046/j.1365-2362.1999.00463.x"><li><a href="http://dx.doi.org/10.1046/j.1365-2362.1999.00463.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chlamydia+pneumoniae+reactive+T+lymphocytes+in+the+walls+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chlamydia+pneumoniae+reactive+T+lymphocytes+in+the+walls+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0001895-McMillan1" id="pone.0001895-McMillan1"></a>McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg  29: 122–7.  <ul class="find" data-citedArticleID="1083316" data-doi="10.1016/s0741-5214(99)70363-0"><li><a href="http://dx.doi.org/10.1016/s0741-5214(99)70363-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Increased+plasma+levels+of+metalloproteinase-9+are+associated+with+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Increased+plasma+levels+of+metalloproteinase-9+are+associated+with+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0001895-Bellosta1" id="pone.0001895-Bellosta1"></a>Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, et al.  (1998) HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol  18: 1671–8.  <ul class="find" data-citedArticleID="1083256" data-doi="10.1161/01.atv.18.11.1671"><li><a href="http://dx.doi.org/10.1161/01.atv.18.11.1671" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HMG-CoA+reductase+inhibitors+reduce+MMP-9+secretion+by+macrophages." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HMG-CoA+reductase+inhibitors+reduce+MMP-9+secretion+by+macrophages.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0001895-Nagashima1" id="pone.0001895-Nagashima1"></a>Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, et al.  (2002) A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg  36: 158–63.  <ul class="find" data-citedArticleID="1083320" data-doi="10.1067/mva.2002.123680"><li><a href="http://dx.doi.org/10.1067/mva.2002.123680" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+3-hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitor%2C+cerivastatin%2C+suppresses+production+of+matrix+metalloproteinase-9+in+human+abdominal+aortic+aneurysm+wall." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+3-hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitor%2C+cerivastatin%2C+suppresses+production+of+matrix+metalloproteinase-9+in+human+abdominal+aortic+aneurysm+wall.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0001895-Luan1" id="pone.0001895-Luan1"></a>Luan Z, Chase AJ, Newby AC (2003) Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Bio  23: 769–75.  <ul class="find" data-citedArticleID="1083314" data-doi="10.1161/01.atv.0000068646.76823.ae"><li><a href="http://dx.doi.org/10.1161/01.atv.0000068646.76823.ae" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Statins+inhibit+secretion+of+metalloproteinases-1%2C+-2%2C+-3%2C+and+-9+from+vascular+smooth+muscle+cells+and+macrophages." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Statins+inhibit+secretion+of+metalloproteinases-1%2C+-2%2C+-3%2C+and+-9+from+vascular+smooth+muscle+cells+and+macrophages.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0001895-Wilson2" id="pone.0001895-Wilson2"></a>Wilson WR, Evans J, Bell PR, Thompson MM (2005) HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg  30: 259–62.  <ul class="find" data-citedArticleID="1083360" data-doi="10.1016/j.ejvs.2005.02.044"><li><a href="http://dx.doi.org/10.1016/j.ejvs.2005.02.044" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HMG-CoA+reductase+inhibitors+%28statins%29+decrease+MMP-3+and+MMP-9+concentrations+in+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HMG-CoA+reductase+inhibitors+%28statins%29+decrease+MMP-3+and+MMP-9+concentrations+in+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0001895-Thompson2" id="pone.0001895-Thompson2"></a>Thompson S (1994) Why sources of heterogeneity in meta-analysis should be investigated. BMJ  309: 1351–1355.  <ul class="find" data-citedArticleID="1083342" data-doi="10.1136/bmj.309.6965.1351"><li><a href="http://dx.doi.org/10.1136/bmj.309.6965.1351" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Why+sources+of+heterogeneity+in+meta-analysis+should+be+investigated." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Why+sources+of+heterogeneity+in+meta-analysis+should+be+investigated.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0001895-Cronenwett1" id="pone.0001895-Cronenwett1"></a>Cronenwett JL (1996) Variables that affect the expansion rate and rupture of abdominal aortic aneurysms. Ann N Y Acad Sci  800: 56–67.  <ul class="find" data-citedArticleID="1083266" data-doi="10.1111/j.1749-6632.1996.tb33298.x"><li><a href="http://dx.doi.org/10.1111/j.1749-6632.1996.tb33298.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Variables+that+affect+the+expansion+rate+and+rupture+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Variables+that+affect+the+expansion+rate+and+rupture+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0001895-Limet1" id="pone.0001895-Limet1"></a>Limet R, Sakalihassan N, Albert A (1991) Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg  14: 540–8.  <ul class="find" data-citedArticleID="1083308" data-doi="10.1016/0741-5214(91)90249-t"><li><a href="http://dx.doi.org/10.1016/0741-5214(91)90249-t" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Determination+of+the+expansion+rate+and+incidence+of+rupture+of+abdominal+aortic+aneurysms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Determination+of+the+expansion+rate+and+incidence+of+rupture+of+abdominal+aortic+aneurysms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0001895-Hirsch1" id="pone.0001895-Hirsch1"></a>Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, et al.  (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease. Circulation  113: 463–654.  <ul class="find" data-citedArticleID="1083288" data-doi="10.1161/circulationaha.106.174526"><li><a href="http://dx.doi.org/10.1161/circulationaha.106.174526" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ACC%2FAHA+2005+Practice+Guidelines+for+the+management+of+patients+with+peripheral+arterial+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ACC%2FAHA+2005+Practice+Guidelines+for+the+management+of+patients+with+peripheral+arterial+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0001895-Kramer1" id="pone.0001895-Kramer1"></a>Kramer BS, Wilentz J, Alexander D, Burklow J, Friedman LM, et al.  (2006) Getting it right: being smarter about clinical trials. PLoS Med  3(6): e144.  <ul class="find" data-citedArticleID="1083298" data-doi="10.1371/journal.pmed.0030144"><li><a href="http://dx.doi.org/10.1371/journal.pmed.0030144" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Getting+it+right%3A+being+smarter+about+clinical+trials." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Getting+it+right%3A+being+smarter+about+clinical+trials.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0001895-Berger1" id="pone.0001895-Berger1"></a>Berger VW (2004) Does the Prentice criterion validate surrogate endpoints? Stat Med  23: 1571–8.  <ul class="find" data-citedArticleID="1083258" data-doi="10.1002/sim.1780"><li><a href="http://dx.doi.org/10.1002/sim.1780" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Does+the+Prentice+criterion+validate+surrogate+endpoints%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Does+the+Prentice+criterion+validate+surrogate+endpoints%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.XML" value="131929"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.PDF" value="154841"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g001.PNG_L" value="41334"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g001.PNG_M" value="44855"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g001.PNG_S" value="7450"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g001.TIF" value="112658"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g001.PNG_I" value="26578"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t001.PNG_L" value="327755"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t001.PNG_M" value="162156"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t001.PNG_S" value="18320"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t001.TIF" value="1602894"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t001.PNG_I" value="55140"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t002.PNG_L" value="237238"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t002.PNG_M" value="132124"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t002.PNG_S" value="14695"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t002.TIF" value="1133000"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t002.PNG_I" value="41247"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g002.PNG_L" value="46302"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g002.PNG_M" value="37493"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g002.PNG_S" value="5782"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g002.TIF" value="104502"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.g002.PNG_I" value="12651"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t003.PNG_L" value="104230"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t003.PNG_M" value="58229"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t003.PNG_S" value="9792"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t003.TIF" value="514274"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t003.PNG_I" value="18296"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t004.PNG_L" value="117600"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t004.PNG_M" value="48070"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t004.PNG_S" value="9245"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t004.TIF" value="590306"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t004.PNG_I" value="15004"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t005.PNG_L" value="169378"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t005.PNG_M" value="68349"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t005.PNG_S" value="10355"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t005.TIF" value="817132"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001895.t005.PNG_I" value="20546"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001895&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001895" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001895&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001895&volume=&issue=&title=The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis&author_name=Idris%20Guessous%2C%20Daniel%20Periard%2C%20Diane%20Lorenzetti%2C%20Jacques%20Cornuz%2C%20William%20A.%20Ghali&start_page=1&end_page=10" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001895" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895&amp;t=The%20Efficacy%20of%20Pharmacotherapy%20for%20Decreasing%20the%20Expansion%20Rate%20of%20Abdominal%20Aortic%20Aneurysms%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895&title=The%20Efficacy%20of%20Pharmacotherapy%20for%20Decreasing%20the%20Expansion%20Rate%20of%20Abdominal%20Aortic%20Aneurysms%3A%20A%20Systematic%20Review%20and%20Meta-Analysis&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895&amp;title=The%20Efficacy%20of%20Pharmacotherapy%20for%20Decreasing%20the%20Expansion%20Rate%20of%20Abdominal%20Aortic%20Aneurysms%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001895&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001895';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20The%20Efficacy%20of%20Pharmacotherapy%20for%20Decreasing%20the%20Expansion%20Rate%20of%20Abdominal%20Aortic%20Aneurysms%3A%20A%20Systematic%20Review%20and%20Meta-Analysis http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001895" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001895" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">

















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22ACE+inhibitors%22" title="Search for articles in the subject area:'ACE inhibitors'"><div class="flagText">ACE inhibitors</div></a>
              <div data-categoryid="38057" data-articleid="26614"
                   data-categoryname="ACE inhibitors"
                   class="flagImage" title="Flag 'ACE inhibitors' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Aneurysms%22" title="Search for articles in the subject area:'Aneurysms'"><div class="flagText">Aneurysms</div></a>
              <div data-categoryid="25575" data-articleid="26614"
                   data-categoryname="Aneurysms"
                   class="flagImage" title="Flag 'Aneurysms' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antihypertensives%22" title="Search for articles in the subject area:'Antihypertensives'"><div class="flagText">Antihypertensives</div></a>
              <div data-categoryid="26097" data-articleid="26614"
                   data-categoryname="Antihypertensives"
                   class="flagImage" title="Flag 'Antihypertensives' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Calcium+channels%22" title="Search for articles in the subject area:'Calcium channels'"><div class="flagText">Calcium channels</div></a>
              <div data-categoryid="51963" data-articleid="26614"
                   data-categoryname="Calcium channels"
                   class="flagImage" title="Flag 'Calcium channels' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cohort+studies%22" title="Search for articles in the subject area:'Cohort studies'"><div class="flagText">Cohort studies</div></a>
              <div data-categoryid="25265" data-articleid="26614"
                   data-categoryname="Cohort studies"
                   class="flagImage" title="Flag 'Cohort studies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Diuretics%22" title="Search for articles in the subject area:'Diuretics'"><div class="flagText">Diuretics</div></a>
              <div data-categoryid="25781" data-articleid="26614"
                   data-categoryname="Diuretics"
                   class="flagImage" title="Flag 'Diuretics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+therapy%22" title="Search for articles in the subject area:'Drug therapy'"><div class="flagText">Drug therapy</div></a>
              <div data-categoryid="18461" data-articleid="26614"
                   data-categoryname="Drug therapy"
                   class="flagImage" title="Flag 'Drug therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22NSAIDs%22" title="Search for articles in the subject area:'NSAIDs'"><div class="flagText">NSAIDs</div></a>
              <div data-categoryid="32731" data-articleid="26614"
                   data-categoryname="NSAIDs"
                   class="flagImage" title="Flag 'NSAIDs' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=4284'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=1626'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=431&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
